PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome
Alimentary Pharmacology & Therapeutics2014Vol. 39(5), pp. 532–539
Citations Over TimeTop 10% of 2014 papers
Jiacheng Shen, Grace Lai–Hung Wong, Henry Lik‐Yuen Chan, Hoi–Yun Chan, D. K.‐W. Yeung, Ruth Chan, A. M.‐L. Chim, Anthony W.H. Chan, Paul Cheung‐Lung Choi, Jean Woo, Chiu‐Wing Winnie Chu, Vincent Wai‐Sun Wong
Abstract
The G allele in PNPLA3 rs738409 increases the risk of NAFLD in the general population, especially in subjects without metabolic syndrome, independent of dietary pattern and metabolic factors.
Related Papers
- → Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease(2017)30 cited
- → Prevalence of fatty liver in metabolic syndrome(2020)16 cited
- → Does Non-Alcoholic Fatty Liver Disease (NAFLD) Increase Cardiovascular Risk?(2008)17 cited
- Prevalence survey on fatty liver and metabolic syndrome(2009)
- Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease(2019)